Impact Stories
Stories illustrating how regulatory science impacts the lives and health of people
To illustrate the unique value of CDER’s regulatory science investments we have developed a series of “impact stories” that describe recent advances by our researchers and the impacts of these discoveries on drug development and the public health.
Designing Sound Clinical Trials That Incorporate Real-World Data
August 19, 2022
Through-Container Quantitative Screening of Hand Sanitizers
March 18, 2022
Exploiting Real-World Data to Optimize the Use of Antibiotics
November 9, 2021
Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia
November 10, 2020
Capturing Patient Experience Through Deep Learning
August 13, 2018
Developing the Tools to Evaluate Complex Drug Products: Peptides
October 2, 2017
Developing New Ways to Evaluate Bioequivalence for Topical Drugs
September 22, 2017
Addressing Concerns About the Quality of Generic Drugs for Treating Epilepsy
September 22, 2017
Helping to Better Communicate the Risks and Benefits in Prescription Drug Advertising
September 22, 2017